Neurogene Therapeutics (NGNE) - Kapitalisasi marang bathi
The market dynamics of Neurogene Inc. (NGNE) securities demonstrate the -4.30 indicator. Neurogene Inc. (NGNE) relies on its own centers in New York and Texas, which ensures stability in the development of gene therapies. The implementation of automated systems accelerates the search for effective vectors through mass screening. Meanwhile, structural flexibility is maintained by outsourcing production and trials to external contractors to minimize capital expenditures.
Rincian metrik komprehensif lan analitis Neurogene Corp (NGNE)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal Neurogene Inc.|NGNE - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Neurogene Therapeutics|NGNE - Gunggung utang perusahaan|Utang-utang marang nilai buku Neurogene Inc.|NGNE - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Neurogene|Likuiditas darurat neurogene.com
- data bathi resik lan rasio valuasi:
NGNE - Penghasilan resik|Penghasilan resik sing dikarepake Neurogene Inc.|NGNE - Pangali P/E|Kapitalisasi marang proyeksi bathi Neurogene Inc|NGNE - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Neurogene Inc.|NGNE - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Neurogene|NGNE - Bathi resik saben saham sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan neurogene.com|NGNE - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Neurogene Inc.
Ringkesan analisis perusahaan:NGNE (neurogene.com)
Assessing the asset quality of Neurogene Inc. (NGNE) requires an analysis of the price-to-earnings ratio. The company's trailing P/E reflects market expectations for return on investment relative to current earnings. For this gene therapy developer, this indicator measures the premium attributed to its strong reputation in treating Rett syndrome. Monitoring this metric allows for the timely identification of business overvaluation or undervalued capital potential.
Analisis perusahaan pesaing
Pangali rega marang bathi BIIB (biogen.com)|Pangali P/E NBIX|RGC - Kapitalisasi marang bathi|Axsome Therapeutics Inc - Koefisien rega marang bathi|Pangali P/E ACADIA Corp ACAD|XENE - Rasio rega marang bathi|Nilai perusahaan marang bathi resik VKTX (vikingtherapeutics.com)|Supernus (SUPN) - Rasio rega marang bathi|Kapitalisasi marang bathi Catalyst Pharma (CPRX)|DNLI (Denali Therapeutics Inc) - Pangali P/E|HRMY - Rasio kapitalisasi marang bathi resik|Pangali P/E BHVN|AMLX - Kapitalisasi marang bathi|Rasio rega marang bathi Trevi Therapeutics, Inc. TRVI|PRAX: Pangali rega marang bathi|Anavex Corp - Pangali P/E|Kapitalisasi marang bathi CeriBell EEG|PRTA (prothena.com) - Koefisien rega marang bathi|Alector - Nilai perusahaan marang bathi resik|ANNX (Annexon) - Pangali P/E|Omeros Corp. (OMER) - Periode bali modal bisnis|Rasio rega marang bathi AC Immune Corp (ACIU)|Voyager Corp - Pangali rega marang bathi|Pangali P/E NMRA (Neumora Therapeutics)|SCLX - Koefisien rega marang bathi|TVGN: Koefisien rega marang bathi|Periode bali modal bisnis Alpha Cognition ACOG|Cognition Therapeutics, Inc. (CGTX) - Rasio rega marang bathi|Pangali rega marang bathi IKT|SAVA (Cassava Sciences, Inc.) - Pangali P/E|ASRT - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi Coya Therapeutics, Inc. (COYA)|vistagen.com - Pangali rega marang bathi|Pangali P/E OVID (Ovid Therapeutics)|Acumen Pharmaceuticals, Inc (ABOS) - Kapitalisasi marang bathi|CRVO - Rasio rega marang bathi|ATHE (Alterity Therapeutics) - Pangali rega marang bathi|CLNN: Pangali P/E|Kapitalisasi marang bathi PepGen (PEPG)|Koefisien rega marang bathi JUNS|Pangali P/E Relmada Corp|Rasio rega marang bathi Annovis Bio, Inc. (ANVS)|GRCE (gracetx.com) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Firefly Neuroscience AIFF|ANEW Medical (KLTO) - Kapitalisasi marang bathi|NRSN - Rasio rega marang bathi|RVPH (Reviva Pharmaceuticals, Inc.) - Pangali rega marang bathi|MTVA: Pangali P/E|Kapitalisasi marang bathi neuraxis.com (NRXS)|Koefisien rega marang bathi HSDT|Pangali P/E Passage Bio Corp|Rasio rega marang bathi Neuphoria Therapeutics Inc. (NEUP)|NERV (Minerva) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Athira Pharma, Inc. ATHA|addextherapeutics.com (ADXN) - Kapitalisasi marang bathi|Alzamend - Pangali P/E|Rasio kapitalisasi marang bathi resik Cyclerion Therapeutics (CYCN)|PTIX: Pangali P/E|Kapitalisasi marang bathi Pasithea Therapeutics Corp. (KTTA)|Rasio rega marang bathi Cortigent Inc|Pangali rega marang bathi ATXI (avenuetx.com)|Pangali P/E BCLI|CARA - Kapitalisasi marang bathi|Chromocell Therapeutics Corporation - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik ELYM|Intra-Cellular - Pangali P/E|Periode bali modal bisnis longboardpharma.com LBPH|Marinus Pharmaceuticals, Inc. (MRNS) - Rasio rega marang bathi|Pangali rega marang bathi NKGN|NRBO (NeuroBo) - Pangali P/E|Koefisien rega marang bathi Sage Therapeutics Inc (SAGE)|Koefisien rega marang bathi SNPX (Synaptogenix, Inc.)|Periode bali modal bisnis trevena.com|Rasio rega marang bathi Vigil Neuroscience, Inc. VIGL|WENA: Pangali rega marang bathi|Cerevel - Pangali P/E
